Published November 9, 2019
| Version v1
Dataset
Open
Dataset for "Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group"
Authors/Creators
- 1. Ocular Oncology Service, Department of Ophthalmology, University of Helsinki and Helsinki University Hospital, Helsinki, Finland
- 2. Department of Medical Oncology, Institut Curie, Paris, France
- 3. Department of Ocular Oncology, Institut Curie, Paris, France
- 4. Department of Hematology and Medical Oncology, Charité, Berlin, Germany
- 5. Department of Ophthalmology, Charité, Berlin, Germany
- 6. Department of Ophthalmology, University of Padova, Padova, Italy
- 7. Department of Oncology, University Hospital, Lausanne, Switzerland
- 8. Hopital Jules Gonin, University Hospital, Lausanne, Switzerland
- 9. Department of Ophthalmology, Croix-Rousse Hospital and Centre Léon Bérard, Lyon, France
- 10. Clatterbridge Centre for Oncology, Bebington, Wirral, Merseyside, United Kingdom
- 11. St Paul's Eye Unit, Royal Liverpool University Hospital, Liverpool, United Kingdom
Description
Raw data corresponding to the paper entitled: "Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group" published in Am. J. Ophthalmol. 2016 Aug;168:217-226 by Kivelä et al.
Notes
Raw data in original Stata (.dta) as well as in SPSS Portable file (.por) and SAS Transport (.xpt) formats, corresponding to the paper entitled "Validation of a Prognostic Staging for Metastatic Uveal Melanoma: A Collaborative Study of the European Ophthalmic Oncology Group". Variables: unique identifier, year of diagnosis of metastases, treatment group: DTIC=1 fotemustine=2 treosulfan-gemcitabine=3 other chemotherapy=4 chemoembolization=5 interferon=6 vaccine=7 only surgery=8 surgery with chemotherapy=9 best supportive care=10 other=11, any treatment: no=0 yes=1, any surgical treatment: no=0 yes=1, ECOG 0=1 1-2=2 3-4=3, serum or plasma alkaline phosphatase level relative to upper normal limit, the largest diameter of the largest metastasis in cm, predicted overall survival in months, Helsinki University Hospital Working Formulation Stage: IVa=1 IVb=2 IVc=3, observed survival in months, Working Formulation Stage equivalent: >12 months=1 12-6 months=2 <6 months=3, TNM M category: M1a=1 M1b=2 M1c=3 .
Files
Describe_Stata_dataset_labels.pdf
Additional details
Related works
- Is supplement to
- Journal article: 10.1016/j.ajo.2016.06.002 (DOI)